Status:

COMPLETED

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

Lead Sponsor:

Doroana, Maria Manuela, M.D.

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Eurotrials Brasil Consultores Cientificos Ltda

Conditions:

HIV Infections

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to evaluate the efficacy of raltegravir with optimized background therapy (OBT) in multiple-experienced HIV infected patients, measured by the proportion of patients with ...

Detailed Description

Considering its novel mechanism of action, potency, safety and tolerability, and pharmacokinetic profile, raltegravir has been used in several clinical scenarios. Since its initial clinical use in mul...

Eligibility Criteria

Inclusion

  • Male or female patients, aged 18 years or older
  • ARV multi-experienced patients (i.e. experienced at least two prior regimens) with need to change current ARV therapy, including:
  • HIV-1 infected patients with documented therapeutic failure,
  • HIV-2 infected patients with documented therapeutic failure
  • HIV infected patients in virologic suppression who needed to change ARV due to inacceptable toxicity, as determined by the investigator, including patients who needed to replace T20
  • Raltegravir-naïve patients who initiated raltegravir since the EAP Program, with optimized background therapy(OBT)
  • Patient who has been followed at the same clinical site since the start of raltegravir

Exclusion

  • Acute or decompensated chronic hepatitis. Patients with serum aminotransferase levels 10 times the upper limit of the normal range or higher (grade 4)
  • Patients who presented resistance to drugs included in OBT (namely, etravirine, darunavir or maraviroc)
  • Non-existing medical records for viral load and TCD4 at baseline, week 24 and 48

Key Trial Info

Start Date :

April 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2010

Estimated Enrollment :

151 Patients enrolled

Trial Details

Trial ID

NCT01190124

Start Date

April 1 2010

End Date

July 1 2010

Last Update

May 19 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.